NEW YORK, March 03, 2016 -- EXL (NASDAQ:EXLS), a leading provider of Operations Management and Analytics services, today announced the appointment of Patrick Rice as Senior Vice President, Business Development for EXL Healthcare. Rice is a 20-year industry veteran and most recently Managing Director and overall Sales Lead for Accenture’s North American Health and Public Services Group.
“Patrick Rice has demonstrated the ability to build multi-tower transformational client relationships within the healthcare industry, and I am excited to have him join our rapidly growing practice,” said Rembert de Villa, Executive Vice President and Head of EXL Healthcare. “Healthcare is a strategic priority at EXL, and Patrick combines industry expertise with the ability to implement effective go-to-market approaches and to scale sales operations.”
Rice also held the roles of Sales Lead for Accenture’s North American Provider Portfolio and for large, complex sales in the healthcare, pharmaceutical and manufacturing markets. Previously, Rice was Senior Director for Business Development at Convergys, where he led the team that won what was at the time one of the largest contracts in the business process outsourcing (BPO) industry. Throughout his leadership roles, Rice has exceled at optimizing the sales process and building solution teams that support clients in improving results through operational excellence. Rice holds a BA in Economics from Cortland State University.
“This is a great time to be joining EXL Healthcare,” Rice said. “I was attracted to the EXL’s focus, growth, deep talent and integrated capabilities. The disruption occurring in the healthcare industry has created opportunities for new innovative approaches to support payers’ and providers’ goals of increasing quality while reducing the cost of care. I look forward to helping EXL scale its already strong footprint in this industry.”
EXL Healthcare delivers strategic solutions that integrate operations management, analytics, technology and consulting in the areas of population health management, revenue cycle management, payment integrity, customer experience, and revenue optimization. EXL Healthcare was named to the “Winner’s Circle” in both the “HfS Blueprint Report: Healthcare Payer Operations 2015” and the “HfS Blueprint Report: 2015 Population Health and Care Management Business Services.”
About EXL
EXL (NASDAQ:EXLS) is a leading operations management and analytics company that helps businesses enhance growth and profitability in the face of relentless competition and continuous disruption. Using our proprietary award-winning Business EXLerator Framework™, which integrate analytics, automation, benchmarking, BPO, consulting, industry best practices and technology platforms to look deeper to help companies improve global operations, enhance data-driven insights, increase customer satisfaction, and manage risk and compliance. EXL serves the insurance, healthcare, banking and financial services, utilities, travel, transportation and logistics industries. Headquartered in New York, New York, EXL has more than 24,000 professionals in locations throughout the United States, Europe, Asia (primarily India and Philippines), Latin America, Australia and South Africa. For more information, visit www.exlservice.com.
Media contact: Michael Sherrill Vice President, Marketing [email protected] 646-419-0778


Star Entertainment Leadership Shake-Up Deepens as CFO and COO Exit Amid Ongoing Restructuring
BP Nears $10 Billion Castrol Stake Sale to Stonepeak
Winter Storm Disrupts Northeast Travel as Snow and Ice Blanket New York, New Jersey
Trump Administration Probes Corporate DEI Programs, Raising Questions for Google Stock
Warner Bros. Discovery Shares Slide Amid Report of Potential Paramount Skydance Lawsuit
Boeing Secures Multi-Billion Dollar Defense Contracts for F-15IA Jets and E-4B Aircraft Support
China’s LandSpace Takes Aim at SpaceX With Reusable Rocket Ambitions
Nvidia to Acquire Groq in $20 Billion Deal to Boost AI Chip Dominance
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccines Portfolio
GLP-1 Weight Loss Pills Set to Reshape Food and Fast-Food Industry in 2025
South Korean Court Clears Korea Zinc’s $7.4 Billion U.S. Smelter Project, Shares Surge
Nike Stock Jumps After Apple CEO Tim Cook Buys $2.9M Worth of Shares
Brazilian Oil Workers’ Strike Continues as Key Petrobras Union Rejects Proposal
Nvidia and Groq Strike Strategic AI Inference Licensing Deal
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccine Portfolio
Hanwha Signals Readiness to Build Nuclear-Powered Submarines at Philly Shipyard for U.S. Navy
Lloyds Banking Group to Close Invoice Factoring Business by End of 2025 



